2023-510391-31-00
Not yet recruiting
Phase 4
The effect of different antibiotic protocols for dental implant surgery on peri-implant tissue health and on oral microbiome and resistome
Universita Degli Studi Di Genova1 site in 1 country80 target enrollmentStarted: April 16, 2024Last updated:
Overview
- Phase
- Phase 4
- Status
- Not yet recruiting
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Mean bone loss
Overview
Brief Summary
The aim of the study is to evaluate if the short-span antibiotic therapy with amoxicillin per os is not inferior compared to the long-span antibiotic prescription in favouring peri-implant tissue healing (i.e. less peri-implant bone loss), while at the same time reducing the risk of developing antimicrobial resistance.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patients requiring one single implant or partial implant-supported rehabilitation in an edentulous area of the posterior mandible or maxilla
Exclusion Criteria
- •Patients unable to commit to follow-up - General contraindications to implant surgery - Immuno-suppressed/immune-compromised patients - Patients irradiated in the head and/or neck - Uncontrolled diabetes - Pregnancy, childbearing potential, breastfeeding - Smoking habit - Untreated periodontal disease (Caton et al, J Clin Periodontol 2018) - Poor oral hygiene and motivation (plaque index > 20%) - Addiction to alcohol or drugs - Psychiatric problems and/or unrealistic expectations - Patients with an acute infection (abscess) or suppuration in the site intended for implant placement - Patients treated or under treatment with intravenous amino-bisphosphonates - Patients referred only for implant placement if the follow-up cannot be done at the treatment center - Patients participating in other studies, if the present protocol could not be fully adhered to - Patients with allergy/hypersensitivity to penicillin or drug excipients - Patients recently treated with antibiotics for other indications
Outcomes
Primary Outcomes
Mean bone loss
Mean bone loss
Secondary Outcomes
- - Incidence of biological and technical complications - Implant survival rate (CSR) - Antibiotic sensitivity 1 week before and 2-6 months after implant insertion - Peri-implant myco-, microbiome and resistome 1 week before and 2-6 months after implant insertion - Salivary miRNomics 1 week before and 2 months after implant insertion - Adverse reactions - Development of a 3D bone model (sub-study) - Plaque index (PI), Bleeding on probing (BOP) and probing depth (PPD) a at 3, 6 and 12 months
Investigators
Maria Menini
Scientific
Universita Degli Studi Di Genova
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Phase 4
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized (SHORTEN-2) clinical trial with a DOOR/RADAR analysis.2023-508441-41-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla306
Recruiting
Phase 4
Efficacy of 7 days versus 14 days of antibiotic therapy for acute pyelonephritis in kidney transplant recipients2024-513328-40-00Assistance Publique Hopitaux De Paris, Assistance Publique Hopitaux De Paris470
Recruiting
Phase 3
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial)2024-515398-90-01Stichting Amsterdam UMC300
Not yet recruiting
Phase 4
Comparison of continuing intravenous antibiotic therapy with switching to oral antibiotics in clinically stable patients with blood infections caused by Gram-negative bacteria (INVEST study)2024-517308-13-00Tan Tock Seng Hospital Pte. Ltd.150
Recruiting
Phase 4
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis.2024-511719-40-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla284